col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


96 Results       Page 1

 [1] 
MediaMedica: Terapevticheskii arkhiv
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―03 Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19 Alebai U. Sabitov, Dmitry A. Lioznov, Konstantin V. Zhdanov, Elena P. Tikhonova, Elena V. Esaulenko, Olga P. Kovtun, et al. (+2)
2 [GO] 2024―Apr―16 Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19 Alebai U. Sabitov, Dmitry A. Lioznov, Konstantin V. Zhdanov, Elena P. Tihonova, Elena V. Esaulenko, Pavel V. Sorokin
3 [GO] 2024―Apr―16 Prevention and treatment of COVID-19 based on post-genomic pharmacological analysis: Systematic computer analysis of 290,000 scientific articles on COVID-19 Ivan Yu. Torshin, Olga A. Gromova, Alexander G. Chuchalin
4 [GO] 2024―Apr―16 The role of spectral analysis of cough sounds in the diagnosis of COVID-19 Andrey V. Budnevsky, Evgeny S. Ovsyannikov, Sergey N. Avdeev, Oleg N. Choporov, Sofya N. Feigelman, Alexey V. Maksimov
5 [GO] 2024―Apr―16 Pulmonary fibrosis after a new coronavirus infection - versions and controversies: A review Evgeny I. Shchepikhin, Evgene I. Shmelev, Atadzhan E. Ergeshov
6 [GO] 2024―Apr―16 Clinical and morphological features of lung injury long-term after SARS-CoV-2 recovery Gulsara E. Baimakanova, Maria Samsonova, Andrey L. Chernyaev, Andrey S. Kontorschikov, Andrey S. Belevskiy
7 [GO] 2024―Mar―14 Dynamics of hospital mortality in COVID-19 pandemia Diana F. Gareeva, Irina A. Lakman, Alexander A. Agapitov, Liana F. Sadikova, Paruir A. Davtian, Valeriia L. Kayumova, et al. (+9)
8 [GO] 2024―Mar―14 Relationships of doctors and patients of the infection hospital during the 1st and 2nd waves of the COVID-19 pandemic Tatyana E. Romanova, Olga P. Abaeva, Nadezhda V. Prisyazhnaya, Sergey V. Romanov, Vitaly A. Berdutin
9 [GO] 2024―Jan―31 Long-term consequences of COVID-19 in patients with functional bowel disorders, rehabilitation prospective of microbiocenosis-oriented therapy Mikhail B. Patsenko
10 [GO] 2024―Jan―31 Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients Oleg O. Yanushevich
11 [GO] 2023―Dec―22 The possibilities of impulse oscillometry in the diagnosis of the lung function disorders after COVID-19 Olga I. Savushkina, Pavel A. Astanin, Galina V. Nekludova, Sergey N. Avdeev, Andrey A. Zaytsev
12 [GO] 2023―Dec―22 Exudative pericarditis with tamponade after COVID-19. Case report Leonid I. Dvoretsky, Svetlana A. Rachina, Maria G. Poltavskaya, Denis A. Andreev, Elena V. Tarykina, Natalya A. Plaksina, et al. (+2)
13 [GO] 2023―Dec―22 Features of the course of COVID-19 in patients with type 2 diabetes mellitus Elena A. Karaseva, Vladimir A. Martynov, Tatyana E. Filatova, Viktor V. Maleev, Vladimir Yu. Grishin, Nikita S. Pronin, et al. (+2)
14 [GO] 2023―Dec―22 The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial Vladimir V. Nikiforov, Vladimir A. Petrov, Anatoly A. Stremoukhov., Marina G. Avdeeva, Yury G. Shvarts, Irina E. Kravchenko, et al. (+7)
15 [GO] 2023―Dec―22 Сardiac arrhythmias in people who have had a coronavirus infection COVID-19: A review Nail R. Yamoldinov, Mikhail V. Dudarev, Denis S. Sarksyan, Viktor V. Maleev
16 [GO] 2023―Dec―22 Pathogenetic approaches to the correction of vascular homeostasis in patients with COVID-19: A review Andrey A. Shuldyakov, Anna N. Smagina, Kristina Kh. Ramazanova, Elena P. Lyapina, Yusef R. Chabbarov, Natalia A. Sheshina, Alena A. Zhuk
17 [GO] 2023―Dec―22 Predictors of thromboembolic complications in patients with severe SARS-CoV-2 coronavirus infection Valery I. Podzolkov, Elena V. Volchkova, Aida I. Tarzimanova, Anna E. Bragina, Alexander A. Ivannikov, Ekaterina E. Bykova, et al. (+3)
18 [GO] 2023―Oct―11 Opportunities to improve the prognosis of the course of COVID-19 for at-risk patients Evgeniya V. Tavlueva, Olga A. Slyusareva, Anna A. Panfilova, Arnold E. Markarov
19 [GO] 2023―Oct―11 The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic Sergey N. Avdeev, Vladimir P. Chulanov, Ekaterina I. Alexeeva, Olga A. Aleshina, Aleksey V. Bereznikov, Oleg N. Kotenko, et al. (+6)
20 [GO] 2023―Oct―11 Acute non-calculous cholecystitis in a young aged patient with COVID-19: A case report Vladimir V. Salukhov, Yaroslav R. Lopatin, Alexey A. Minakov, Аlexey B. Bogomolov, Ekaterina O. Salosina
21 [GO] 2023―Sep―29 Association between cardio-ankle vascular index and markers of thrombosis in hospitalized patients COVID-19 Valery I. Podzolkov, Anna E. Bragina, Aida I. Tarzimanova, Ekaterina S. Ogibenina, Ilya I. Shvedov, Alexander A. Ivannikov, et al. (+2)
22 [GO] 2023―Sep―29 Features of the course and adverse events risk of coronavirus infection COVID-19 in hematological diseases (data from the CHRONOS19 register for the Primorsky Territory, intermediate stage) Angelina V. Talko, Vera A. Nevzorova, Vitaliy S. Dubov, Nikita S. Muzychenko, Eldar R. Gurbanov, Sergei K. Dubov, et al. (+2)
23 [GO] 2023―Sep―29 Diseases of the gastrointestinal tract in the context of COVID-19 infection: present and future challenges: A review Igor V. Maev, Mikhail A. Osadchuk
24 [GO] 2023―Sep―29 Right ventricle free wall rupture during transcatheter occluder implantation in a patient with postinfarction rupture of the interventricular septum and COVID-19-associated myocarditis. Case report Dmitry V. Pevzner, Tatiana S. Sukhinina, Egor N. Anufriev, Natalia S. Kostritca, Eric A. Avetisyan, Victor N. Shitov, et al. (+5)
25 [GO] 2023―Sep―29 The survival prediction of hospitalized patients with COVID-19: the role of chitotriosidase level in peripheral blood Ekaterina S. Schelkanovtseva, Georgy O. Isaev, Olga Yu. Mironova, Alexander A. Balakhonov, Alexey V. Skvortsov, Ilya O. Nagornov, et al. (+3)
26 [GO] 2023―Aug―17 Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study Marina S. Lebedkina, Daria S. Fomina, Zinaida Y. Mutovina, Ulyana A. Mаrkina, Pavel O. Bogomolov, Vladimir P. Chulanov, et al. (+2)
27 [GO] 2023―Aug―17 Potential for infusion correction of COVID-19-associated endotheliopathy Ionas S. Simutis, Viacheslav A. Ratnikov, Alexey N. Scheglov, Olga V. Nikolaeva, Gennady A. Boyarinov, Alexander A. Sapegin, et al. (+3)
28 [GO] 2023―Feb―24 Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19 Marina V. Zhuravleva, Vladimir P. Chulanov, Julia V. Gagarina, Elena A. Shabalina
29 [GO] 2023―Feb―24 Risk factors for adverse outcomes in elderly patients with asthma and severe COVID-19 at the hospital and early post-hospital stages Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdniakova, Anna E. Vlasenko, Tatiana Iu. Gneusheva, Irina V. Baytemerova
30 [GO] 2023―Feb―24 Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies Anna A. Roppelt, Marina S. Lebedkina, Anton A. Chernov, Tatiana S. Kruglova, Olga A. Mukhina, Yulia D. Yukhnovskaya, et al. (+6)
31 [GO] 2023―Jan―16 Treatment of toxic hepatitis in COVID-19 patients Igor V. Maev, Rafik I. Shaburov, Alexandr I. Pavlov, Alevtina I. Molodova, Aram G. Karakozov, Sergey P. Kazakov, et al. (+4)
32 [GO] 2022―Dec―26 Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19 Oksana V. Stanevich, Evgeny A. Bakin, Aleksandra A. Korshunova, Alexandra Ya. Gudkova, Aleksey A. Afanasev, Irina V. Shlyk, et al. (+3)
33 [GO] 2022―Dec―26 Predictors of severe course of new coronavirus infection (COVID-19): study design Tatyana A. Mishchenko, Polina A. Ermakova, Anna A. Ermakova, Lyudmila P. Tseller, Yulia A. Rogozhkina, Margarita I. Verteletskaya, et al. (+2)
34 [GO] 2022―Dec―26 Clinical cases of complicated diverticulitis against the background of severe course COVID-19. Case report Natalia Yu. Pshenichcnaya, Zhanna B. Ponezheva, Asiyat R. Marzhokhova, Zaira F. Kharaeva, Liana E. Balagova, Madina Yu. Marzhokhova, Irina V. Shestakova
35 [GO] 2022―Dec―26 Clinical case of mucormycosis in patient COVID-19. Case report Guzel M. Nurtdinova, Azat M. Suleymanov, Ian I. Bayazitov, Zarema R. Khismatullina, Fanil B. Shamigulov, Ruslan M. Gumerov, et al. (+7)
36 [GO] 2022―Dec―26 Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial Marina G. Avdeeva, Oksana N. Belousova, Ekaterina A. Orlova, Rustem F. Khamitov, Yury G. Shvarts, Irina E. Kravchenko
37 [GO] 2022―Dec―26 Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review Igor V. Maev, Mikhail A. Osadchuk
38 [GO] 2022―Dec―26 Regional Vascular Center in a COVID-19 pandemic: what changed in 2020 compared to 2019 in patients with <i>ST</i> Elevation Myocardial Infarction? Anna G. Syrkina, Vyacheslav V. Ryabov
39 [GO] 2022―Dec―26 Prospects and possibilities for the treatment of patients with long COVID-19 syndrome Marine M. Tanashyan, Anton A. Raskurazhev, Polina I. Kuznetsova, Petr A. Bely, Kira Ia. Zaslavskaya
40 [GO] 2022―Dec―26 The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting Tatiana S. Kruglova, Daria S. Fomina
41 [GO] 2022―Dec―26 Pulmonary fibrosis in patients with COVID-19: A review Alexander G. Chuchalin
42 [GO] 2022―Nov―22 The role of systemic immune activation in the development of thyroid dysfunction in COVID-19 Evgenia A. Kolpakova, Alina R. Elfimova, Larisa V. Nikankina, Ekaterina A. Troshina
43 [GO] 2022―Nov―22 Efficacy of <i>Saccharomyces boulardii</i> CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 Igor V. Maev, Dmitry N. Andreev, Philipp S. Sokolov, Aleksei К. Fomenko, Mikhail K. Devkota, Nikolai G. Andreev, Andrew V. Zaborovsky
44 [GO] 2022―Nov―22 Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection Oleg V. Maltsev, Kristina V. Kasyanenko, Konstantin V. Kozlov, Konstantin V. Zhdanov, Igor I. Lapikov
45 [GO] 2022―Oct―12 Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19 Vladimir P. Chulanov, Bulat A. Bakirov, Natalia N. Vezikova, Vladimir N. Gorodin, Marina V. Zhuravleva, Alena I. Zagrebneva, et al. (+5)
46 [GO] 2022―Oct―12 Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity Elizaveta V. Starikova, Dmitry N. Andreev, Julia S. Galeeva, Philipp S. Sokolov, Dmitry E. Fedorov, Aleksander I. Manolov, et al. (+18)
47 [GO] 2022―Aug―12 Peculiarities of hemostasis in patients with COVID-19 Anna I. Kalinskaya, Oleg A. Dukhin, Ivan A. Molodtsov, Aleksandra S. Anisimova, Denis A. Sokorev, Antonina K. Elizarova, et al. (+7)
48 [GO] 2022―Aug―12 New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19 Aleksandr V. Gorelov, Oleg V. Kalyuzhin, Madina I. Bagaeva
49 [GO] 2022―Aug―12 Features of the intestine conditions at patients with a new coronavirus infection Tatiana В. Topchiy, Maria D. Ardatskaya, Ludmila I. Butorova, Leonid V. Маslovskii, Оleg N. Мinushkin
50 [GO] 2022―Aug―04 Risk factors of kidney injury in patients with COVID-19 Anastasia A. Shchepalina, Natalia V. Chebotareva, Aram A. Kitbalian, Pavel P. Potapov, Anna A. Nartova, Larisa A. Akulkina, et al. (+3)
51 [GO] 2022―Aug―04 Diagnostic and treatment difficulties in kidney damage in the patient with generalized sarcoidosis during COVID-19. Case report Marina V. Lebedeva, Natalia V. Chebotareva, Vladimir D. Beketov
52 [GO] 2022―Jun―17 Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit Ulyana A. Mаrkina, Daria S. Fomina, Marina S. Lebedkina, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva, et al. (+4)
53 [GO] 2022―Jun―17 Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment Alexey I. Khripun, Andrey V. Starshinin, Yulia O. Antipova, Mariana A. Lysenko, Yulia V. Urozhaeva, Olga F. Gavrilenko, et al. (+10)
54 [GO] 2022―Jun―17 Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs Maxim A. Korolev, Elena A. Letyagina, Alexey E. Sizikov, Larisa A. Bogoderova, Yuliya B. Ubshaeva, Vitaly O. Omelchenko, et al. (+4)
55 [GO] 2022―May―26 A new approach in the diagnosis of lung lesions in patients with COVID-19: lung ultrasound protocol versus CT scan Marina A. Saidova, Ani A. Avalyan, Mareta A. Galaeva, Mikhail B. Belkind
56 [GO] 2022―Apr―19 Hydrogen effect on the mechanisms of mucosal immunity in patients with COVID-19 Oxana A. Svitich, Irina A. Baranova, Nadezhda O. Kryukova, Alexander V. Poddubikov, Alexandra B. Vinnitskaya, Natalia D. Abramova, et al. (+4)
57 [GO] 2022―Apr―19 Differential diagnosis of pneumonia as a complication of nasal liquorrhea in the context of the COVID-19 pandemic: Case report Nadezhda A. Chernikova, Elizaveta V. Shelesko, Oleg I. Sharipov, Olga N. Ershova, Pavel L. Kalinin, Maxim A. Kutin, Dmitry V. Fomichev
58 [GO] 2022―Mar―30 Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19 Vadim A. Akhmedov
59 [GO] 2022―Mar―30 COVID-19 as a trigger of autoimmune hepatitis. Case report Ekaterina A. Volchkova, Kristina S. Legkova, Tatiana B. Topchy
60 [GO] 2022―Mar―17 ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis Gregory P. Arutyunov, Ekaterina I. Tarlovskaya, Alexander G. Arutyunov, Yuri N. Belenkov, Alexandra O. Konradi, Yury M. Lopatin, et al. (+191)
61 [GO] 2022―Mar―17 Assessment of factors affecting the probability of hospitalization of COVID-19 patients with concomitant pathology and development of a prognostic model based on them Irina A. Lizinfeld, Natalia Yu. Pshenichcnaya, Liubov E. Parolina, Grigorii Yu. Zhuravlev, Viktor V. Maleev, Vasiliy G. Akimkin
62 [GO] 2022―Feb―02 The role and place of pathogenetic therapy with glucocorticosteroid hormones in the treatment of patients with novel coronavirus infection (COVID-19) Dmitrii O. Efremov, Vladimir B. Beloborodov
63 [GO] 2022―Feb―02 Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19 Tatyana S. Kruglova, Darya S. Fomina, Nataliуa G. Poteshkina, Nadija F. Frolova, Irina P. Beloglazova, Zinaida Yu. Mutovina, et al. (+6)
64 [GO] 2022―Feb―02 Peculiarities of blood coagulation disorders in patients with COVID-19 Natalia G. Evtugina, Svetlana S. Sannikova, Alina D. Peshkova, Svetlana I. Safiullina, Izabella A. Andrianova, Gulzada R. Tarasova, et al. (+4)
65 [GO] 2022―Feb―02 Acute disseminated encephalomyelitis and myelitis associated with new coronavirus infection COVID-19. Case report Luiza T. Akhmedzhanova, Olga N. Voskresenskaia, Aleksei I. Isaikin, Elizaveta V. Ermilova, Tatiana I. Nasonova, Pavel A. Chernousov, Vladimir V. Rusin
66 [GO] 2022―Feb―02 COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic Mikhail L. Zubkin, Nadiya F. Frolova, Irina G. Kim, Anzhela I. Ushakova, Sergei S. Usatiuk, Rustam T. Iskhakov, et al. (+5)
67 [GO] 2022―Feb―02 Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020 Natalia Yu. Pshenichnaya, Elena N. Kareva, Irina A. Leneva, Vilya A. Bulgakova, Irina E. Kravchenko, Irina V. Nikolaeva, et al. (+12)
68 [GO] 2022―Feb―02 Clinical portrait of a patient with COVID-19. The experience of a multidisciplinary clinic Gulsara E. Baimakanova, Igor E. Khatkov, Galina A. Dudina., Anzhelika S. Chegodar, Konstantin A. Rumyantsev, Filipp S. Sviridov, et al. (+9)
69 [GO] 2021―Nov―05 Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy Tatiana Yu. Demidova, Kristina G. Lobanova, Sergey N. Perekhodov, Michail B. Antsiferov, Olga S. Oynotkinova
70 [GO] 2021―Nov―05 Mineral metabolism and COVID-19: is there a connection? Irina S. Maganeva, Anna M. Gorbacheva, Ekaterina E. Bibik, Elizaveta A. Aboisheva, Anna K. Eremkina, Natalia G. Mokrysheva
71 [GO] 2021―Oct―10 Tactics of antihypertensive therapy during COVID-19 pandemic Valery I. Podzolkov, Anna Е. Bragina, Yulia N. Rodionova, Galina I. Bragina, Ekaterina E. Bykova
72 [GO] 2021―Oct―10 COVID-19 and features of cardiovascular involvement Elena V. Tsyganova, Nataliia V. Glukhoedova, Aleksandra S. Zhilenkova, Tatiana I. Fedoseeva, Elena N. Iushchuk, Natalia S. Smetneva
73 [GO] 2021―Sep―29 Organizing the medical care for the COVID-19 patients in non-infectious Moscow hospital: reassignment experience I. G. Nikitin, A. V. Melekhov, M. A. Sayfullin, S. S. Agafonov, S. A. Bedritskiy, A. A. Vishninskiy, et al. (+18)
74 [GO] 2021―Sep―29 Novel coronavirus infection COVID-19: extrapulmonary manifestations I. V. Maev, A. V. Shpektor, E. Yu. Vasilyeva, V. N. Manchurov, D. N. Andreev
75 [GO] 2021―Sep―29 Umifenovir and coronavirus infections: a review of research results and clinical practice I. A. Leneva, N. Y. Pshenichnaya, V. A. Bulgakova
76 [GO] 2021―Sep―29 The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2 G. P. Arutiunov, E. I. Tarlovskaia, N. A. Koziolova, M. V. Boldina, M. M. Batiushin, A. S. Ametov, et al. (+22)
77 [GO] 2021―Sep―08 Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19 Olga A. Gromova, Ivan I. Torshin, Alexander G. Chuchalin, Elena N. Kozhevnikova, Svetlana I. Malyavskaya
78 [GO] 2021―Sep―08 Gastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy Maria D. Ardatskaya, Ludmila I. Butorova, Marina A. Kalashnikova, Nelli R. Nugaeva, Yury V. Ovchinnikov, Olga S. Oynotkinova, et al. (+5)
79 [GO] 2021―Sep―08 Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic Oleg O. Ianushevich, Igor V. Maev, Natella I. Krikheli, Oleg V. Levchenko, Irina V. Rogova, Andrei V. Zaborovskii, et al. (+16)
80 [GO] 2021―Jul―11 Assessment of the influence of different factors on the risk of the development of a new coronavirus infection in patients with contrast induced acute kidney injury Georgy O. Isaev, Olga Iu. Mironova, Viktor V. Fomin
81 [GO] 2021―Jun―23 Experience of the preventive use of the drug Riamilovir in the foci of coronavirus infection (COVID-19) Alebay U. Sabitov, Pavel V. Sorokin, Svetlana Yu. Dashutina
82 [GO] 2021―Jun―23 Liver and COVID-19: possible mechanisms of damage Marina G. Mnatsakanyan, Aleksandr P. Pogromov, Aleksei S. Lishuta, Victor V. Fomin, Olga S. Volkova, Olga V. Tashchyan, et al. (+2)
83 [GO] 2021―Jun―23 Efficiency of application of sorbed probiotics in complex therapy of pneumonia caused by SARS-CoV-2. Part 1. Heating clinical displays period Elena R. Meskina, Elena E. Tselipanova, Marima K. Khadisova, Lidiya A. Galkina, Tatyana V. Stashko
84 [GO] 2021―Jun―23 2019 Coronavirus disease (COVID-19): contribution of rheumatology Evgeny L. Nasonov
85 [GO] 2021―Jun―23 New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Case report Daria G. Rumiantceva, Margarita M. Urumova, Shandor F. Erdes
86 [GO] 2021―Apr―09 Evaluation of the effectiveness of Riamilovir in the complex therapy of patients with COVID-19 Kristina V. Kasyanenko, Konstantin V. Kozlov, Oleg V. Maltsev, Igor I. Lapikov, Vera V. Gordienko, Valerian V. Sharabhanov, et al. (+2)
87 [GO] 2021―Apr―09 COVID-19 and human security Aleksandr G. Chuchalin
88 [GO] 2021―Apr―09 COVID-19 and the small intestine Sergei D. Bakharev, Elena V. Baulo, Svetlana V. Bykova, Saria R. Dbar, Asfold I. Parfenov
89 [GO] 2021―Feb―26 BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic Oleg V. Kalyuzhin, Tatiana M. Andronova, Alexander V. Karaulov
90 [GO] 2021―Feb―08 BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic O. V. Kalyuzhin, T. M. Andronova, A. V. Karaulov
91 [GO] 2021―Feb―08 Experience of olokizumab use in COVID-19 patients V. N. Antonov, G. L. Ignatova, O. V. Pribytkova, S. S. Sleptsova, E. A. Strebkova, E. A. Khudyakova, et al. (+12)
92 [GO] 2020―Dec―26 The role of vitamin D in seasonal acute respiratory viral infections and COVID-19 E. A. Pigarova, A. A. Povalyaeva, L. K. Dzeranova, L. Y. Rozhinskaya, N. G. Mokrysheva
93 [GO] 2020―Dec―26 Risk factors for the early development of septic shock in patients with severe COVID-19 P. V. Glybochko, V. V. Fomin, S. V. Moiseev, S. N. Avdeev, A. G. Yavorovskiy, M. Yu. Brovko, et al. (+36)
94 [GO] 2020―Dec―26 Pathogenesis, diagnosis, prevention and treatment of disseminated intravascular coagulation syndrome in COVID-19 infection P. A. Vorobyev, A. P. Momot, L. S. Krasnova, A. P. Vorobiev, A. K. Talipov
95 [GO] 2020―Nov―24 Iodine deficiency disorders as a non-infectious epidemic: a look at the problem at the tome of COVID-19 pandemic G. A. Mel’nichenko, E. A. Troshina, G. A. Gerasimov
96 [GO] 2020―Oct―14 COVID-19 and cardiovascular diseases I. E. Chazova, O. I. Mironova
 [1] 

96 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec